CYTOMEGALOVIRUS INFECTIONS
Clinical trials for CYTOMEGALOVIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets dangerous virus in vulnerable transplant patients
Disease control Recruiting nowThis early-stage study is testing whether specially selected immune cells from a donor can safely treat cytomegalovirus (CMV) infections in people who have received a stem cell transplant. The trial is for patients whose CMV infection isn't improving with standard antiviral medic…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: EARLY_PHASE1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New strategy to shield transplant patients from dangerous virus rebound
Disease control Recruiting nowThis study is testing if a drug called letermovir can prevent cytomegalovirus (CMV) infection from coming back in high-risk kidney or kidney/pancreas transplant patients. It will enroll about 90 adult patients who have already been treated for a CMV infection. The goal is to see …
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE3 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC
-
New software aims to speed up diagnosis of dangerous pregnancy virus
Diagnosis Recruiting nowThis study is testing a new computer software tool called MyCMV, designed to help doctors and midwives interpret blood test results for a common virus called cytomegalovirus (CMV) during pregnancy. The goal is to see if the software can identify CMV infections in the first trimes…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
New strategy aims to shield vulnerable transplant patients from dangerous virus
Prevention Recruiting nowThis study is testing if giving an antiviral drug called letermovir for a longer period (up to 24 weeks) can better prevent dangerous CMV infections in high-risk adults who have received a stem cell transplant from a donor. CMV is a common virus that can cause serious illness in …
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC
-
Researchers track dangerous virus breakthrough in lung transplant patients
Knowledge-focused Recruiting nowThis study aims to learn how often a dangerous virus called CMV breaks through preventive medication in high-risk lung transplant patients. Researchers will follow 40 patients who receive standard preventive treatment after transplant to monitor infection rates and medication sid…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC